1450POsimertinib treatment for patients with EGFR exon 20 insertion positive non-small cell lung cancer. (23rd October 2018) - van Veggel, B; van der Wekken, A; Hashemi, S; Cornelissen, R; Monkhorst, K; Heideman, D; Radonic, T; Smit, E F; Schuuring, E; De Langen, J